Bile acid receptor TGR5, NADPH Oxidase NOX5-S and CREB Mediate Bile Acid-Induced DNA Damage in Barrett's Esophageal Adenocarcinoma Cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Dan ^a   Cao, Weibiao ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREB1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GPBAR1 PROTEIN, HUMAN; NOX5 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; TAURODEOXYCHOLIC ACID;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DNA DAMAGE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA DAMAGE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; NADPH OXIDASE 5; RECEPTORS, G-PROTEIN-COUPLED; TAURODEOXYCHOLIC ACID;

EID: 84982161580     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31538     Document Type: Article

References (25)

1. Kauer, W. K. & Stein, H. J. Emerging concepts of bile refux in the constellation of gastroesophageal refux disease. J Gastrointest Surg 14 Suppl 1, S9-16, doi:10.1007/s11605-009-1014-4 (2010).
2. Jankowski, J. A. & Anderson, M. Review article: management of oesophageal adenocarcinoma-control of acid, bile and infammation in intervention strategies for Barrett's oesophagus. Aliment Pharmacol Ter 20 Suppl 5, 71-80, discussion 95-76, doi: 10.1111/j.1365-2036 (2004).
3. Attwood, S. E. et al. Duodenoesophageal refux and the development of esophageal adenocarcinoma in rats. Surgery 111, 503-510 (1992).
4. Clark, G. W. et al. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1, 252-261 (1994).
5. Fein, M. et al. Duodenoesophageal refux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 2, 260-268, doi: S1091-255X(98)80021-8 (1998).
6. Das, K. M. et al. Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model. Int J Cancer 128, 274-282, doi: 10.1002/ijc.25343 (2011).
7. Peng, S. et al. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. Am J Physiol Gastrointest Liver Physiol 307, G129-G139, doi: 10.1152/ajpgi.00085.2014 (2014).
8. Mills, K. D., Ferguson, D. O. & Alt, F. W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 194, 77-95, doi: 060 (2003).
9. McAdam, E. et al. Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of refux-induced cell signalling in esophageal cells. Carcinogenesis 33, 2035-2043, doi: 10.1093/carcin/bgs241 (2012).
10. Huo, X. et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol 301, G278-G286, doi: ajpgi.00092.2011 (2011).
11. Hong, J. et al. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59, 170-180, doi: gut.2009.188375 (2010).
12. Houten, S. M., Watanabe, M. & Auwerx, J. Endocrine functions of bile acids. EMBO J 25, 1419-1425, doi: 7601049 (2006).
13. Katsuma, S., Hirasawa, A. & Tsujimoto, G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329, 386-390, doi: S0006-291X(05)00203-2 (2005).
14. Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489, doi: nature04330 (2006).
15. Lawrence, J. et al. Changes in gamma-H2AX expression in irradiated feline sarcoma cells: an indicator of double strand DNA breaks. Res Vet Sci 94, 545-548, doi: S0034-5288(13)00009-X (2013).
16. Bonner, W. M. et al. GammaH2AX and cancer. Nat Rev Cancer 8, 957-967, doi: nrc2523 (2008).
17. Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313 (2007).
18. Fu, X. et al. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281, 20368-20382 (2006).
19. Boonstra, J. J. et al. Verifcation and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst 102, 271-274, doi: 10.1093/jnci/djp499 (2010).
20. Gonzalez, G. A. & Montminy, M. R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680 (1989).
21. Shankar, D. B. et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7, 351-362, doi: S1535-6108(05)00088-7 (2005).
22. Shankar, D. B. & Sakamoto, K. M. The role of cyclic-AMP binding protein (CREB) in leukemia cell proliferation and acute leukemias. Leuk Lymphoma 45, 265-270 (2004).
23. Hughes, S. J. et al. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Cancer Res 57, 5571-5578 (1997).
24. Li, D. & Cao, W. Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 306, G863-G872, doi: ajpgi.00321.2013 (2014).
25. Cao, W. et al. MAPK mediates PKC-dependent contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 285, G86-G95 (2003).